BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 33899949)

  • 1. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
    Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.
    Oliver JR; Persky MJ; Wang B; Duvvuri U; Gross ND; Vaezi AE; Morris LGT; Givi B
    Cancer; 2022 Feb; 128(4):685-696. PubMed ID: 34762303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
    Sload R; Silver N; Jawad BA; Gross ND
    Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
    Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
    Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
    Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
    Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232
    [No Abstract]   [Full Text] [Related]  

  • 8. Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma.
    Magliocca KR; Kaka AS; Barrow EM; Studer MB; Griffith CC; Ernst J; Meade T; Balicki A; Boyce BJ; Schmitt NC; Bur AM; Schmitt AC; Jackson R; Steuer CE; Beitler JJ; Patel MR
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):80-87. PubMed ID: 36538901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
    Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
    J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
    Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
    Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population.
    Viros Porcuna D; Pollan Guisasola C; Viña Soria C; Cirauqui Cirauqui B; Pardo Muñoz L; Collurá F; Mesia Nin R
    Clin Transl Oncol; 2020 Aug; 22(8):1303-1311. PubMed ID: 31858433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid Usage and Prescribing Predictors Following Transoral Robotic Surgery for Oropharyngeal Cancer.
    Abt NB; Holcomb AJ; Feng AL; Suresh K; Mokhtari TE; McHugh CI; Parikh AS; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
    Laryngoscope; 2021 Jun; 131(6):E1888-E1894. PubMed ID: 33210756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients With Early-Stage Oropharyngeal Squamous Cell Carcinoma.
    Nguyen AT; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Shiao SL; Ho AS; Zumsteg ZS
    JAMA Oncol; 2020 Oct; 6(10):1555-1562. PubMed ID: 32816023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom.
    O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V
    Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Trends in 30-Day Readmission Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
    Nyirjesy SC; McCrary HC; Zhao S; Judd RT; Farlow JL; Seim NB; Ozer E; Agrawal A; Old MO; Rocco JW; Kang SY; Haring CT
    JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):133-141. PubMed ID: 38153724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
    Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
    Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.
    Holcomb AJ; Herberg M; Strohl M; Ochoa E; Feng AL; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Sadow P; Faquin W; Faden D; Deschler DG; Varvares MA; Lin DT; Fakhry C; Ryan WR; Richmon JD
    Head Neck; 2021 Aug; 43(8):2434-2444. PubMed ID: 33856083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of HPV-Negative Oropharyngeal Cancer Treated With Transoral Robotic Surgery.
    Jackson RS; Stepan K; Bollig C; Sharma RK; Patel M; Massa S; Puram SV; Zevallos JP; Pipkorn P; Zenga J
    Otolaryngol Head Neck Surg; 2021 Nov; 165(5):682-689. PubMed ID: 33752484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.
    Groysman M; Yi SK; Robbins JR; Hsu CC; Julian R; Bauman JE; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2022; 43(1):103243. PubMed ID: 34583290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.